Drugs

Latest publications

Search publications

Search result publications

73 results found.

Freeman, T.P., Pol, P. van der, Kuijpers, W., Wisselink, J., Da, R.K., Rigter, R., Laar, M. van, ... Niesink, R. (2018). Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands. Psychological Medicine. doi:10.1017/S0033291717003877

Berman, A.H., Hoybye, M.T., & Blankers, M. (2017). Editorial on IJBM Special Issue—E-Health Interventions for Addictive Behaviors. International Journal of Behavioral Medicine, 24(5), 641-645. doi:10.1007/s12529-017-9684-x

Blankers, M. & Mujcic, A. (2017). E-health and m-health: using new technologies to respond to drug problems. EMCDDA Drugs Library.

Brunt, T.M., Atkinson, A.M., Nefau, T., Martinez, M., Lahaie, E., Malzcewdki, A. ... Brandt, S.D. (2017). Online test purchased new psychoactive substances in 5 different European countries: a snapshot study of chemical composition and price. The International Journal of Drug Policy, 44(mei). doi:10.1016/j.drugpo.2017.03.006

Brunt, T.M., Berg, J. van den, Pennings, E., & B. Venhuis (2017). Adverse effects of levamisole in cocaine users: a review and risk assessment. Archives of Toxicology, 91(6), 2303-2313. doi:10.1007/s00204-017-1947-4

Giné, C.V., Vilamala, M.V., Measham, F., Brunt, T.M., Bücheli, A., Paulos, C., ... Barratt, M.J. (2017). The utility of drug checking services as monitoring tools and more: a response to Pirona et al. The International Journal of Drug Policy(45), 46-47. doi:10.1016/j.drugpo.2017.05.018

Gouwe, D. van der, Rigter, S., & Brunt, T.M. (2017). Focus on cryptomarkets and online reviews too narrow to debate harms of drugs bought online. Addiction(november). doi:10.1111/add.14060

Helsper, C.W., Janssen, M.P., Essen, G.A. van, Croes, E.A., Veen, C. van der, Wit, A.G. de, & Wit, N.J.de (2017). Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands. The International Journal of Drug Policy(47), 117-125. doi:10.1016/j.drugpo.2017.07.022

Hondebrink, L., Nugteren-van Lonkhuyzen, J.J., Rietjens, S.J., Brunt, T.M., Venhuis, B., Soerdjbalie-Maikoe, V., ... Vries, I. (2017). Fatalities, cerebral hemorrhage, and severe cardiovascular toxicity after exposure to the new psychoactive substance 4-fluoroamphetamine: a prospective cohort study. Annals of Emergency Medicine(september). doi:10.1016/j.annemergmed.2017.07.482

Quaglio, G., Schellekens, A., Blankers, M., Hoch, E., Karapiperis, T., Esposito, G., ... Kiefer, F. (2017). A brief outline of the use of new technologies for treating substance use disorders in the european union. European Addiction Research, 23(4), 177-181. doi:10.1159/000478904

Verweij, K.J.H., Treur, J.L., Vreeker, A., Brunt, T.M., Willemsen, G., Boomsma, D.I., & Vink, J.M. (2017). Heritability of lifetime ecstasy use. Drug and Alcohol Dependence (178), 66-69. doi:10.1016/j.drugalcdep.2017.05.007

Vreeker, A., Burg, B.G. van der, Laar, M. van, & Brunt, T.M. (2017). Characterizing users of newpsychoactive substances using psychometric scales for risk-related behavior. Addictive Behaviors, 70(juli), 72-78. doi:10.1016/j.addbeh.2017.02.010

Vrolijk, R.Q., Brunt, T.M., Vreeker, A., & Niesink, R.J.M. (2017). Is online information on ecstasy tablet content safe? Addiction, 112(1), 94-100. doi:10.1111/add.13559

Wijers, C.H., Litsenburg, R.T. van, Hondebrink, L., Niesink, R.J., & Croes, E.A. (2017). Acute toxic effects related to 4-fluoroamphetamine. The Lancet, 389(10069), 600. doi:10.1016/S0140-6736(17)30281-7

Brunt, T.M., Nagy, C., Bücheli, A., Martins, D., Ugarte, M., Beduwe, C., & Ventura Vilamala, M. (2016). Drug testing in Europe: Monitoring results of the Trans European Drug Information (TEDI) project. Drug Testing and Analysis(2). doi:10.1002/dta.1954

Gouwe, D. van der, Brunt, T.M., Laar, M. van, & Pol, P. van der (2016). Purity, adulteration and price of drugs bought online versus offline in the Netherlands. Addiction. doi:10.1111/add.13720

Laar, M. van, Pol, P. van der, & Niesink, R . (2016). Limitations to the Dutch cannabis toleration policy : Assumptions underlying the reclassification of cannabis above 15% THC. International Journal of Drug Policy. doi:10.1016/j.drugpo.2016.02.011

Litjens, R.P., & Brunt, T.M. (2016). How toxic is ibogaine? Clinical Toxicology. doi:10.3109/15563650.2016.1138226

Amsterdam, J. van, Brunt, T., & Brink, W. van den (2015). The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. Journal of Psychopharmacology, 29(3), 254-263. doi:10.1177/0269881114565142

Benschop, A., Liebregts, N., Pol, P. van der, Schaap, R., Buisman, R., Laar, . . . Graaf, R. de (2015). Reliability and validity of the Marijuana Motives Measure among young adult frequent cannabis users and associations with cannabis dependence. Addictive Behaviors, 40, 91-95. doi:10.1016/j.addbeh.2014.09.003

Recent publications